| An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates N Zabaleta, W Dai, U Bhatt, C Hérate, P Maisonnasse, JA Chichester, ... Cell host & microbe 29 (9), 1437-1453. e8, 2021 | 70 | 2021 |
| A review of the preclinical and clinical efficacy of remdesivir, hydroxychloroquine, and lopinavir-ritonavir treatments against COVID-19 D Maciorowski, SZE Idrissi, Y Gupta, BJ Medernach, MB Burns, ... SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (10), 1108-1122, 2020 | 43 | 2020 |
| Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays Y Gupta, D Maciorowski, SE Zak, KA Jones, RS Kathayat, SA Azizi, ... Methods 195, 57-71, 2021 | 37 | 2021 |
| Advancing oncolytic virus therapy by understanding the biology HL Kaufman, D Maciorowski Nature Reviews Clinical Oncology 18 (4), 197-198, 2021 | 34 | 2021 |
| Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy Y Gupta, D Maciorowski, SE Zak, CV Kulkarni, AS Herbert, R Durvasula, ... International Journal of Biological Macromolecules 183, 203-212, 2021 | 33 | 2021 |
| Iron dysregulation in COVID‐19 and reciprocal evolution of SARS‐CoV‐2: Natura nihil frustra facit Y Gupta, D Maciorowski, B Medernach, DP Becker, R Durvasula, ... Journal of cellular biochemistry 123 (3), 601-619, 2022 | 32 | 2022 |
| Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates N Zabaleta, W Dai, U Bhatt, JA Chichester, J Sanmiguel, R Estelien, ... bioRxiv, 2021.01. 05.422952, 2021 | 12 | 2021 |
| Environmental factors and their role in the transmission of SARS-CoV-2 D Maciorowski, D Sharma, A Kunamneni Biosafety and Health 3 (05), 235-237, 2021 | 6 | 2021 |
| Therapeutic and vaccine options for COVID-19: Status after six months of the disease outbreak D Maciorowski, C Ogaugwu, SR Durvasula, R Durvasula, A Kunamneni SLAS DISCOVERY: Advancing the Science of Drug Discovery 26 (3), 311-329, 2021 | 6 | 2021 |
| Molecular insights into severe acute respiratory syndrome coronavirus 2 pathobiology: dissecting the interplay between cellular innate immunity and immune evasion D Maciorowski, S Mohama, MA Alsawi, DJ Ilc, Y Gupta, S El Idrissi, ... Critical Reviews™ in Immunology 40 (6), 2020 | 5 | 2020 |
| Immunogenicity of an AAV-based COVID-19 vaccine in murine models of obesity and aging ZN Maciorowski Dawid, Diop Cheikh, Bhatt Urja, Estelien Reynette, Li Dan ... Viruses 14 (4), 2022 | 4 | 2022 |
| Revealing SARS-CoV-2 functional druggability through multi-target CADD screening of repurposable drugs Y Gupta, D Maciorowski, R Mathur, CM Pearce, DJ Ilc, H Husein, A Bharti, ... Preprints, 2020 | 4 | 2020 |
| Testing-Related and Geo-Demographic Indicators Strongly Predict COVID-19 Deaths in the United States during March of 2020 ALR James B. Hittner, Folorunso O. Fasina, Almira L. Hoogesteijn, Renata ... Biomedical and Environmental Sciences-China CDC 34 (9), 734-738, 2021 | 2* | 2021 |
| Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates U Bhatt, C Herate, R Estelien, F Relouzat, N Dereuddre-Bosquet, ... Vaccines 12 (8), 882, 2024 | | 2024 |
| Smart Wearables and Health DM Sarith Felber Technology and Public Purpose Project, 2023 | | 2023 |
| An AAV-based, room-temperature stable, single dose COVID-19 vaccine N Zabaleta, U Bhatt, C Herate, W Dai, P Maisonnasse, JA Chichester, ... HUMAN GENE THERAPY 32 (19-20), A28-A28, 2021 | | 2021 |
| Immunogenicity of An AAV-Based, Room-Temperature Stable, Single Dose COVID-19 Vaccine in Mouse and NHP N Zabaleta, W Dai, U Bhatt, JA Chichester, J Sanmiguel, R Estelien, ... MOLECULAR THERAPY 29 (4), 119-120, 2021 | | 2021 |
| Immunogenicity of Two AAV-Based COVID-19 Vaccine Candidates in Mouse Models of Aging and Obesity D Maciorowski, N Zabaleta, U Bhatt, C Diop, W Dai, R Estelien, D Li, ... MOLECULAR THERAPY 29 (4), 352-352, 2021 | | 2021 |
| Candidate Selection in BALB/c Mice towards a Single Dose AAV-Based COVID19 Prophylactic Vaccine W Dai, N Zabaleta, U Bhatt, R Estelien, D Li, D Maciorowski, J Sanmiguel, ... MOLECULAR THERAPY 29 (4), 90-90, 2021 | | 2021 |
| A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19 M al. SLAS, 1-15, 2020 | | 2020 |
Prakasha Kempaiah, PhDConsultng Scientist, Mayo Clinic FloridaE-mailová adresa ověřena na: mayo.edu
